Ketamine for Bipolar Depression: Why the Diagnosis Changes the Conversation

Depression can look remarkably similar whether someone has major depressive disorder or bipolar disorder.

Low energy.

Loss of interest.

Poor concentration.

Hopelessness.

Sleep changes.

Difficulty functioning.

But once bipolar disorder enters the picture, the treatment conversation changes.

That is particularly true with ketamine.

Research suggests IV ketamine may rapidly improve depressive symptoms in some people with bipolar depression. But clinicians also have to think about something that receives far less attention in ordinary depression treatment:

Could treatment push mood too far in the other direction?

Bipolar Depression Is Not Simply “More Severe Depression”

Bipolar disorder includes episodes of depression along with a history of mania or hypomania.

That distinction can be easy to miss.

Some people spend far more time depressed than manic. They may seek care during depressive episodes and barely mention a period years earlier when they:

• Slept only a few hours a night without feeling tired

• Became unusually productive

• Talked much faster

• Took unusual financial risks

• Felt unusually powerful or confident

• Became impulsive

• Experienced unusually intense irritability

• Started multiple projects simultaneously

That history can fundamentally change medication decisions.

Why Diagnosis Matters Before Ketamine

Ketamine has substantial evidence behind its use in treatment-resistant unipolar depression.

The evidence in bipolar depression is smaller.

An updated systematic review identified eight studies involving 235 adults with bipolar depression. In those studies, participants receiving IV ketamine generally received it in addition to a mood-stabilizing medication, rather than as an isolated treatment. Across the pooled studies, researchers found encouraging antidepressant responses, but a small number of participants developed hypomanic or manic symptoms. 

Another meta-analysis also found evidence of rapid antidepressant effects while emphasizing that bipolar-specific evidence remains much smaller than the literature for major depressive disorder. 

That is an important distinction between “there is evidence” and “we know everything we need to know.”

We do not.

What Is the Concern About Mania?

A treatment that improves depression can sometimes contribute to a switch into hypomania or mania in someone with bipolar disorder.

Symptoms can include:

• Dramatically reduced need for sleep

• Unusually elevated mood

• Racing thoughts

• Excessive talking

• Increased impulsivity

• Risky spending or sexual behavior

• Grandiosity

• Agitation

• Irritability

A mood switch is not simply a patient “feeling really good.”

It can cause serious personal, financial, occupational, and relationship consequences.

In the systematic review mentioned above, manic or hypomanic symptoms occurred in a small minority of participants. That suggests the risk may be relatively uncommon in monitored research settings, but it is not zero. 

Why Mood Stabilizers Matter

One striking feature of much of the bipolar ketamine research is that ketamine was not being used in isolation.

Participants generally remained on mood-stabilizing treatment.

That might include medications such as lithium, valproate, lamotrigine, or another medication appropriate to the patient’s history.

This is one reason someone with suspected bipolar disorder should not approach ketamine treatment as if it were simply another version of depression treatment.

Medication history matters.

Previous manic or hypomanic episodes matter.

Family history matters.

Recent sleep patterns matter.

What If Someone Has Never Been Diagnosed With Bipolar Disorder?

This is where screening becomes especially important.

Bipolar disorder can be overlooked for years, particularly when depressive episodes dominate the person’s experience.

A patient may say:

“I’ve had depression since college.”

The more useful history might reveal:

“At 25, I went almost a week barely sleeping, started three businesses, spent $20,000, and thought I had finally figured my whole life out.”

That is clinically different.

Before ketamine therapy, patients should mention any history of:

• Mania or hypomania

• Psychiatric hospitalization

• Psychosis

• Major periods of decreased sleep

• Unusual impulsivity

• Antidepressant-induced agitation

• Family history of bipolar disorder

The goal is not to exclude people unnecessarily.

It is to treat the correct condition.

How Effective Could Ketamine Be?

The available research is encouraging.

A systematic review found preliminary evidence that ketamine may produce meaningful antidepressant responses in bipolar depression. However, the authors emphasized the need for more studies on repeated treatment and maintenance. 

Another review reached a similar conclusion: promising, but still preliminary. 

This is not unusual in medicine.

Treatments often move through a period where clinicians see a credible signal before researchers have answered every practical question.

Responsible care means preserving both parts of that sentence:

credible signal and unanswered questions.

What Symptoms Might Improve?

Research primarily evaluates overall depressive symptom severity.

Patients themselves may notice change through things such as:

• Less emotional heaviness

• Return of interest

• Increased ability to complete ordinary tasks

• Reduced hopelessness

• Improved concentration

• Less suicidal thinking in some cases

Anhedonia, the inability to feel pleasure or interest, is another symptom researchers are studying. A 2024 systematic review found preliminary evidence that ketamine may have anti-anhedonic effects in both unipolar and bipolar depression. 

Again, that does not guarantee an individual response.

What Should Be Monitored After Treatment?

For someone with bipolar disorder, improvement needs to be interpreted carefully.

Good signs might include:

• Mood returning toward baseline

• Normal sleep returning

• Better function

• More interest without impulsivity

• Less hopelessness

Potential warning signs include:

• Sleeping dramatically less but feeling energized

• Uncharacteristic spending

• Pressured speech

• Racing thoughts

• Sudden grand plans

• Increased irritability

• Risk-taking

• Family members saying, “You don’t seem like yourself”

Those symptoms should be reported promptly.

Sometimes family or partners notice a mood switch before the patient does.

What About Spravato?

Spravato is FDA-approved for treatment-resistant depression in adults, but its prescribing information is framed around major depressive disorder rather than bipolar depression. Bipolar depression therefore requires its own clinical assessment rather than assuming that an FDA approval for treatment-resistant depression automatically applies to every depressive episode.

This is another situation where diagnosis precedes treatment selection.

The Bottom Line

Ketamine is a promising area of research for bipolar depression.

Small studies and systematic reviews suggest meaningful antidepressant effects in some patients. They also show why bipolar disorder deserves different precautions, particularly around mood stabilization and the possibility of manic or hypomanic switching. 

If someone has bipolar disorder, suspects they may have it, or has ever experienced periods of unusually elevated mood and dramatically reduced sleep, that history belongs in the conversation before treatment begins.

The objective is not merely to move mood upward.

It is to move someone toward stability.

Suggested internal links

• Ketamine infusion therapy

• Antidepressants during ketamine therapy

• Treatment-resistant depression content

• Consultation page